Our customers are pharmaceutical companies, contract research organisations (CROs) and companies operating in the field of biotechnology, which perform in vitro testing for drug selection.
InSimili develops and markets a high-tech product that aims to improve the drug selection process. By limiting the number of wrongly selected drugs, thus reducing failures in the clinical phase, we intend to make this process faster and more effective. Our customers are small, medium and large pharmaceutical companies, contract research organisations (CROs) and companies operating in the field of biotechnology, which perform in vitro testing for drug selection.
We are able to reproduce certain pathological and physiological conditions affecting human tissues in the laboratory so that drugs can be tested under conditions similar to those in which they will be used in humans. This approach will make it possible to better assess the actual effectiveness of drugs.
Viale Giuseppe Fanin, 48 — 40127, Bologna (Italy)
www.insimili.com
info@insimili.com
insimili@pec.buffeti.it
©Copyright 2024 - ALMA MATER STUDIORUM - Università di Bologna - Via Zamboni, 33 - 40126 Bologna - Partita IVA: 01131710376 Privacy - Legal notes - Cookie settings
